Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 95, Issue 3
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
Online download statistics by month:
Online download statistics by month: October 2010 to October 2024
Abstract
Full
Pdf
Oct 2010
173
12
46
Nov 2010
185
9
104
Dec 2010
92
10
48
Jan 2011
214
11
39
Feb 2011
402
49
165
Mar 2011
342
130
212
Apr 2011
149
87
110
May 2011
114
62
68
Jun 2011
83
27
46
Jul 2011
48
31
39
Aug 2011
50
26
34
Sep 2011
72
35
39
Oct 2011
70
36
46
Nov 2011
65
24
36
Dec 2011
62
30
32
Jan 2012
108
47
33
Feb 2012
95
20
27
Mar 2012
86
7
16
Apr 2012
83
21
23
May 2012
70
14
26
Jun 2012
89
17
21
Jul 2012
65
17
21
Aug 2012
47
7
11
Sep 2012
54
14
14
Oct 2012
94
38
19
Nov 2012
72
20
21
Dec 2012
84
6
8
Jan 2013
107
11
25
Feb 2013
79
20
20
Mar 2013
61
7
10
Apr 2013
78
24
13
May 2013
81
8
12
Jun 2013
57
3
10
Jul 2013
48
10
12
Aug 2013
51
7
5
Sep 2013
62
48
17
Oct 2013
88
41
13
Nov 2013
51
5
7
Dec 2013
50
6
12
Jan 2014
65
5
8
Feb 2014
53
7
17
Mar 2014
78
8
14
Apr 2014
83
4
9
May 2014
51
8
7
Jun 2014
53
7
11
Jul 2014
36
9
7
Aug 2014
27
2
5
Sep 2014
40
8
8
Oct 2014
66
4
5
Nov 2014
51
2
9
Dec 2014
30
8
9
Jan 2015
49
8
10
Feb 2015
34
3
5
Mar 2015
43
7
1
Apr 2015
39
13
10
May 2015
41
3
7
Jun 2015
28
4
6
Jul 2015
14
6
4
Aug 2015
33
4
3
Sep 2015
53
2
8
Oct 2015
25
1
3
Nov 2015
54
4
17
Dec 2015
59
1
1
Jan 2016
41
8
8
Feb 2016
49
1
4
Mar 2016
37
1
3
Apr 2016
46
3
2
May 2016
44
2
4
Jun 2016
35
2
6
Jul 2016
19
0
1
Aug 2016
33
3
4
Sep 2016
39
0
0
Oct 2016
28
2
2
Nov 2016
31
4
7
Dec 2016
23
3
4
Jan 2017
20
5
4
Feb 2017
19
1
0
Mar 2017
24
2
6
Apr 2017
26
5
5
May 2017
26
3
1
Jun 2017
26
5
5
Jul 2017
26
0
0
Aug 2017
80
6
2
Sep 2017
166
5
8
Oct 2017
326
1
2
Nov 2017
127
14
1
Dec 2017
87
36
1
Jan 2018
72
28
2
Feb 2018
110
26
1
Mar 2018
53
25
3
Apr 2018
41
18
0
May 2018
74
18
1
Jun 2018
87
25
1
Jul 2018
94
38
1
Aug 2018
69
36
1
Sep 2018
86
37
1
Oct 2018
99
18
2
Nov 2018
43
18
1
Dec 2018
58
22
2
Jan 2019
48
19
2
Feb 2019
79
17
1
Mar 2019
36
1
0
Apr 2019
96
1
0
May 2019
35
11
1
Jun 2019
60
28
4
Jul 2019
52
23
2
Aug 2019
78
25
2
Sep 2019
75
25
2
Oct 2019
91
22
3
Nov 2019
65
21
2
Dec 2019
41
23
1
Jan 2020
51
22
4
Feb 2020
68
25
2
Mar 2020
59
20
2
Apr 2020
74
23
6
May 2020
51
25
3
Jun 2020
65
21
10
Jul 2020
52
17
2
Aug 2020
28
15
1
Sep 2020
83
18
0
Oct 2020
59
17
1
Nov 2020
31
1
1
Dec 2020
126
13
4
Jan 2021
68
2
2
Feb 2021
44
0
1
Mar 2021
48
3
0
Apr 2021
49
3
1
May 2021
20
1
4
Jun 2021
10
7
0
Jul 2021
3
2
7
Aug 2021
6
2
0
Sep 2021
4
3
3
Oct 2021
41
8
1
Nov 2021
59
5
5
Dec 2021
92
4
1
Jan 2022
114
1
1
Feb 2022
41
1
3
Mar 2022
82
4
1
Apr 2022
46
2
2
May 2022
60
8
3
Jun 2022
121
2
2
Jul 2022
50
2
0
Aug 2022
63
6
3
Sep 2022
74
3
0
Oct 2022
83
1
0
Nov 2022
65
3
1
Dec 2022
30
0
0
Jan 2023
57
5
5
Feb 2023
81
3
2
Mar 2023
41
4
0
Apr 2023
59
7
2
May 2023
52
1
0
Jun 2023
30
2
1
Jul 2023
35
0
0
Aug 2023
31
1
0
Sep 2023
37
1
0
Oct 2023
87
3
1
Nov 2023
65
3
1
Dec 2023
86
2
3
Jan 2024
73
4
4
Feb 2024
45
0
9
Mar 2024
44
5
1
Apr 2024
74
2
5
May 2024
65
2
1
Jun 2024
66
2
3
Jul 2024
101
5
0
Aug 2024
50
1
1
Sep 2024
37
1
0
Oct 2024
24
4
1
Total
11266
2110
1877
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?